1992
DOI: 10.1002/j.1460-2075.1992.tb05240.x
|View full text |Cite
|
Sign up to set email alerts
|

A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold.

Abstract: Binding of cellular growth factors to their receptors constitutes a highly specific interaction and the basis for cell and tissue‐type specific growth and differentiation. A unique feature of fibroblast growth factor (FGF) receptors is the multitude of structural variants and an unprecedented degree of cross‐reactivity between receptors and their various ligands. To examine receptor‐ligand specificity within these families of growth factors and receptors, we used genetic engineering to substitute discrete regi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
106
1

Year Published

1995
1995
1998
1998

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 165 publications
(107 citation statements)
references
References 25 publications
(14 reference statements)
0
106
1
Order By: Relevance
“…When such events occur near the 5' end of the gene, ligand-binding domains may be a ected resulting in altered ligandbinding speci®cities. In the case of ®broblast growth factor receptor type 2, for example, alternative exon usage in the immunoglobulin-like loop region results in receptor variants with di erent ligand-binding a nities (Miki et al, 1992;Yayon et al, 1992). These transcripts are expressed in a tissue-and developmental stage-speci®c fashion (Orr-Urtreger et al, 1993;McDonald, 1994;Shi et al, 1994).…”
Section: Discussionmentioning
confidence: 99%
“…When such events occur near the 5' end of the gene, ligand-binding domains may be a ected resulting in altered ligandbinding speci®cities. In the case of ®broblast growth factor receptor type 2, for example, alternative exon usage in the immunoglobulin-like loop region results in receptor variants with di erent ligand-binding a nities (Miki et al, 1992;Yayon et al, 1992). These transcripts are expressed in a tissue-and developmental stage-speci®c fashion (Orr-Urtreger et al, 1993;McDonald, 1994;Shi et al, 1994).…”
Section: Discussionmentioning
confidence: 99%
“…However, the importance of this domain was suggested by a report describing the switch in expression of a FGFR2 isoform with three Ig domains in normal brain to a two Ig domain isoform in malignant astrocytomas (Yamaguchi et al, 1994). While the second Ig domain of FGFR2 has been shown to be important for aFGF binding, the third Ig domain of the receptor governs binding of bFGF or KGF (Miki et al, 1992;Yayon et al, 1992). Interestingly, the KGF receptor (KGFR) and FGFR2 proteins arise from alternative splicing of exons encoding the third Ig domain; the carboxyl terminal half of the third Ig domain of FGFR2 contains sequences responsible for high a nity binding of bFGF while the corresponding region in KGFR mediates KGF binding.…”
Section: Introductionmentioning
confidence: 99%
“…The mutually exclusive exons IIIb and IIIc confer ligand-binding specificities. For FGFR2, the IIIb variant (KGFR) bound FGF-1 and KGF with high affinity and FGF-2 binding was minimal, while the IIIc variant (bek) bound FGF-1 and FGF-2 but not KGF (Mansukhani et al, 1992;Miki et al, 1992;Yayon et al, 1992).…”
Section: Introductionmentioning
confidence: 99%